5 Apps That May Transform Healthcare The HITLAB healthcare innovation competition produced five finalists that may save newborns, prevent blindness and much more.
How to Help Veterans on Mental Health Veterans may suffer a loss of identity, plus companionship and cohesion, when returning to civilian life. "Who has my back?"
How to Calculate Return on Wellness By Tom Emerick Wellness vendors ignore lots of costs when they calculate the return on investment of their programs. Here is what they leave out.
Will Rubio's Measure Undermine ACA? By Alan Katz Sen. Rubio is trying to keep the Obama administration from fully reimbursing insurers with excessive claims under the ACA.
Missing the Boat on ACA Online Tools By David Contorno A staggering number of brokers are talking about which tool to use to automate implementation of ACA benefits. They're too late!
Zenefits’ Problems Are Real but Not Fatal By Alan Katz Insulted by the Zenefits CEO, brokers may revel in his pain but should still take seriously the threat the company represents.
Wising Up on Prostate Tests (Finally) By Tom Emerick Prostate tests have finally started dropping because of evidence that the risks outweigh the benefits -- but there is a joker in the deck.
Integrating Group Life and Voluntary Benefits By Nicole Comstock Data integrity can be a real problem because of the variety of life insurance programs. A fresh start might be the right approach.
Auto Insurance in an Existential Crisis By Stephen Applebaum Alan Demers The 125-year-old, $300 billion U.S. auto insurance industry is caught between runaway inflation and strained consumer wallets.
The Promise of Continuous Underwriting By Bill Deemer Bobby Touran Typically, a risk is underwritten, bound... and forgotten. But new streams of data and automation allow for continuous underwriting.
Convergence and the Insurance Ecosystem By Stephen Applebaum Alan Demers Companies must anticipate the future, innovate beyond their core and transform their capabilities as rapidly as technology allows.
Lemonade's 'Synthetic Agent' Nonsense By Matteo Carbone Desperate for growth, Lemonade produces another howler: A lender receiving a 16% interest rate is presented as a (synthetic) agent.